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ABSTRACT
Clinical microbiology should have a physical presence, but not necessarily on-site diagnostic laboratory
facilities, in each hospital to ensure a quality laboratory-based infection service and strong professional
interaction with clinicians. The adoption of industrial practices and the introduction of new costly
molecular techniques raise the possibility that non-microbiological functions of laboratory management
could be left to management professionals. This remains highly controversial; the advantages must be
contrasted with the potential to disrupt the traditional managerial responsibility of the microbiologist
and the links between the laboratory and clinical staff. Managers and healthcare professionals must
resolve this issue, perhaps with the support of the ESCMID. Views varied, according to current
professional arrangements and size of the laboratory and population served, on whether there should be
a common laboratory for microbiology and other pathology disciplines with joint access to new high-
technology techniques, or whether microbiology must continue as a separate facility. Clinical
microbiology and infection control were viewed as core services that must be present even in smaller
hospitals. Larger community hospitals and teaching centres require a full complement of expertise in
laboratory and clinical practice. Integration of these disciplines within a department of infection is an
emerging concept. A concern was the shortfall in trained expertise because of the ageing nature of
current specialists. The importance of recruiting talented new graduates was emphasised. The
importance of this topic led to a recommendation that an ESCMID working party be established to
investigate the current arrangements of infection services in Europe and to make recommendations for
the future organisation.
Keywords Clinical microbiology, diagnostic laboratory, healthcare management, infection control,
infectious diseases
Clin Microbiol Infect 2005; 11 (Suppl. 1): 41–45
INTRODUCTION
The repertoire of infectious disease challenges is
one of constant change. Established infections
may undergo shifts in virulence or acquire new
resistance mechanisms. The distinction between
community- and hospital-acquired infections is
also becoming blurred for pathogens such as
methicillin-resistant Staphylococcus aureus and
those producing extended-spectrum b-lactamases.
Infectious complications due to travel and migra-
tion have emphasised the reality of the ‘global
village’, which has been compounded by the
emergence of new zoonotic challenges, such as
severe acute respiratory syndrome. Healthcare
systems responsible for the diagnosis, manage-
ment and prevention of infectious disease must
therefore be capable of ﬂexibility and adaptation
if they are to be effective instruments in main-
taining public health.
Within Europe, a variety of specialist infection
services have been developed. These in part
reﬂect the historical approaches to the manage-
ment of infection, but also the different emphases
regarding this management. In broad terms,
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specialist expertise is distributed between diag-
nostic microbiology, clinical services and public
health organisations. These three complementary
specialist groups have provided a framework that
has functioned with varying success in different
countries for the best part of a century. However,
this diversity, which also extends to standardisa-
tion, accreditation and quality assurance, poses
signiﬁcant problems in building an integrated
and international surveillance, alert and response
system.
Another crucial factor in developing meaning-
ful surveillance data is the nature and source of
specimens. There is no effective substitute for
regular sampling and surveillance of a wide range
of clinical samples, especially from infections
arising in the community. Regrettably, commu-
nity-sourced specimens now account for the
minority of samples referred to many diagnostic
laboratories. Too often, ‘outbreaks’ are recognised
once the more severely affected individuals are
admitted to hospital. This provides a ‘tip of the
iceberg’ view of the extent of a problem. ‘Public
health’ microbiology is more than limited samp-
ling of food and water as part of a quality control
arrangement.
Currently, awareness of the threat from emer-
ging and re-emerging infectious diseases, inclu-
ding drug-resistant microorganisms, is increasing
among the public and governments and is being
translated into increasing support for improving
some functions of these professional services and
encouraging closer collaboration of expertise in
Europe. This means that surveillance and alert
systems should be reviewed and the role of
national reference laboratories strengthened if they
are not only to meet these new challenges but also
permit close collaboration with the new European
Centre for Disease Control and Prevention.
The above issues are clearly relevant to an
assessment of the current and a discussion of the
future arrangements for the diagnosis, treatment
and prevention of infection in Europe. This
working group addressed the pivotal role of
diagnostic microbiology and infectious disease
services through a series of challenging questions.
Diverse views were expressed that, in part,
reﬂected the current practice and professional
activities of the participants. Nonetheless, some
general points of principle and some speciﬁc
issues and recommendations emerged from these
discussions.
WHAT IS THE ROLE OF THE
CLINICAL MICROBIOLOGIST
WITHIN AND BEYOND THE
LABORATORY?
The practice of microbiology varies widely in
Europe. Indeed, the multiplicity of terms, such as
academic microbiology, medical microbiology,
clinical microbiology and public health microbio-
logy, attests to variation in emphasis and profes-
sional responsibilities. However, there is a clear
need to distinguish between those involved in the
practice of microbiology as it pertains to humans
and those whose primary responsibility lies in
other ﬁelds. In many countries, the terms medical
microbiology and clinical microbiology are used
interchangeably, although the former is some-
times used to distinguish academic medically
focused microbiology from basic science micro-
biology.
With regard to the professional training and
practice in clinical microbiology, a medical degree
is considered essential in some countries, while in
others science graduates have assumed responsi-
bility for diagnostic services. In others, there is a
close professional partnership between these two
graduate streams. Indeed, reference laboratories
employ a variety of graduate skills, reﬂecting the
complex nature of these organisations, where
clinical, professional, epidemiological, basic sci-
ence, technical and communications expertise are
key to an effective service.
Likewise, there is also diversity in the arrange-
ments of diagnostic laboratories. Historically,
most large teaching hospitals have had on-site
laboratories which include separate clinical
microbiology laboratories. In the case of smaller
hospitals, these were sometimes, and are in some
countries still, contained within a single bio-
pathology laboratory. However, in recent years,
there has been increasing centralisation of diag-
nostic services that support several hospitals. This
concept is being further developed in some
countries through the establishment of ‘microbio-
logy networks’, in which the repertoire of diag-
nostic tests necessary for supporting patient care
and addressing the public health functions within
a large geographical region are shared among a
number of contributing laboratories. This not only
offers economy of scale, but also permits the
establishment of automation and new diagnostics
built around expensive new technologies.
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In some countries, institutes of hygiene continue
to operate, inwhich allmicrobiological samples are
processed distant from any referring hospital or
clinic. As a result of this variety of diagnostic
laboratorymodels, it is inevitable that the nature of
the professional interaction between clinicians and
those responsible for processing specimens will
differ between one that permits ready professional
dialogue and one that primarily communicates
through the medium of a report.
While there is much diversity between coun-
tries, which extends to variation between state-
provided and privately run services, there was
general support for the view that clinical micro-
biology should have a physical presence in each
hospital to ensure not only a continued high-
quality laboratory-based infection service but one
in which there is strong professional interaction
between clinicians and microbiologists. This may
not necessarily demand on-site diagnostic labor-
atory facilities.
One speciﬁc question debated in this category
was, ‘What is the role of the microbiologist within
the laboratory? Should they concentrate on the
professional aspects of their role by overseeing
the range of tests, their application and the
interpretation of the results, but defer the mana-
gerial tasks of budgeting, administration and
personnel management to other professionals?’
The solution is by no means simple, and the views
expressed reﬂected the size of the laboratory in
terms of number of specimens processed, the
number of staff employed, and the demographics
of the population served. However, it is clear that
health service managers are increasingly adopting
industrial management practices, and this argues
for deferring non-microbiological functions of
laboratory management to such professionals,
while the budgetary arrangements must be defen-
ded in order to support an effective service. This
remains a highly controversial issue in many
countries and requires an effective and equitable
solution. Managers and healthcare professionals,
through dialogue and education, must urgently
work together to resolve this issue, perhaps with
the support of an organisation such as the
ESCMID.
Another fundamental question concerned whe-
ther the microbiologist should remain entirely
laboratory-based and provide professional advice
on diagnostic and therapeutic matters by elec-
tronic and telephonic means, or whether a phys-
ical presence within the clinical areas of the
hospital should be encouraged and become the
norm.
The latter practice has emerged as standard in a
number of countries where clinical microbiolo-
gists are involved in consultation work concern-
ing speciﬁc problems, as well as regularly
attending high-risk units such as intensive care,
burns and transplant units and those dealing with
haematological and solid tumours. This clearly
has advantages well beyond the simple provision
of information on diagnostic samples and thera-
peutic questions, since it allows the medical
training and professional expertise of the clinical
microbiologist to be applied to reinforcing infec-
tion control policies and practice, facilitating
medical education, and supporting or leading
research projects. However, this style of practice
is by no means universal, and a more traditional,
entirely laboratory-based role continues in some
centres and indeed in some countries, with few
obvious advantages over the model described
above.
One ﬁnal question raised under this heading
was the role of clinical microbiologists in contri-
buting to multidisciplinary teams and committee
activities within their institutions. The latter often
include committees such as Infection Control,
Drug and Therapeutics, and Antibiotic Policy and
Management. There was universal agreement that
the microbiologist plays a pivotal role in all these
areas, and in many instances acted as chair and
lead. There appeared to be few arguments why
this should not be normal practice. In the case of
the Quality of Care Committees, there was less
recognition of the role and involvement of clinical
microbiologists. In some countries, this is known
as the Audit and Governance Committee, which
is integral to the corporate performance of hospi-
tals. Infection control is one of the key compo-
nents of corporate governance and will continue
to require strong professional support and lead-
ership.
HOW TO APPLY NEW DIAGNOSTIC
AND INFORMATION TECHNOLOGIES
COST-EFFECTIVELY IN THE
MICROBIOLOGY LABORATORY
Traditionally, diagnostic microbiology has been a
relatively low-budget specialty built on generally
simple technology compared to other disciplines
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in pathology, such as clinical chemistry. How-
ever, the past 20 years have seen rapid advance-
ments in the development and marketing of
automated systems, as well as the development
of molecular- and genetic-based diagnostics,
many of which have technology common to all
pathology disciplines, such as PCR-based sys-
tems.
Such technological advances in diagnostics,
when complemented by electronic communica-
tion of results, will continue to improve patient
management provided that they are cost-effective
and clinically relevant, particularly in relation to
turn-around time. They have clearly permitted
faster recognition of infectious disease problems,
increasingly support therapeutic interventions
and facilitate the public health response. How-
ever, these technological developments are often
expensive, and the increasing costs have in part
driven arguments for increased centralisation of
expensive technology. The advantages in terms of
cost and volume, quality control and repertoire of
tests must be contrasted with the potential to
disrupt the traditional managerial responsibility
of the microbiologist and the links between the
laboratory and clinical staff. The speed of change
is also an issue that requires better management
in order to ensure that all players, notably
microbiologists, other laboratory specialists, tech-
nologists, laboratory scientists and management,
are all signed up and supportive of these initia-
tives within a human resource framework that
encourages professional development and the
best ﬁt of skills. This issue is essentially an
extension of the discussion of the need for a
satisfactory solution to the professional–manage-
ment interface referred to earlier.
A further extension of the debate over central-
ised microbiological services is whether there
should be a common laboratory that services
microbiology and other pathology disciplines that
jointly access these new high-technology tech-
niques, or whether microbiology should continue
as a separate facility, with only the most expen-
sive equipment being shared on a ‘hotel’ system.
New methods such as DNA-chip, microarray or
gel-free DNA sequencing are relevant to this.
Again, views varied according to the current
professional arrangements within the countries
represented, as well as with the size of the
laboratory and population served. However,
lessons learned once again from industry clearly
support efﬁcient use of expensive equipment,
with some centralisation and shared costs, main-
tenance and replacement contracts. Where this
arrangement emerges there will be an increasing
need for microbiological training and competence
to be integral to the operation of such centralised
diagnostic facilities, which must retain a robust
patient- and public health-focused operating
policy.
HOW TO BEST INTEGRATE THE
EXPERTISE OF MICROBIOLOGISTS ,
INFECTIOUS DISEASE SPECIALISTS
AND INFECTION CONTROL
SPECIALISTS IN THE MANAGEMENT
OF INFECTION TO MEET THE
SPECIFIC NEEDS OF DIFFERENT
HEALTHCARE FACILITIES
The clinical management of infection is delivered
through a variety of healthcare professionals. The
arrangements differ by country but, in general,
community-based infections are managed largely
through primary care and will continue to be so.
Hospital-based services include a repertoire of
generalists and specialists. Organ-speciﬁc infec-
tions are frequently managed by such specialties
as respiratory medicine (pulmonary tuberculosis)
or gastroenterology ⁄hepatology (hepatitis), while
paediatricians generally provide overall manage-
ment for childhood infections. However, there is a
clear and rapidly advancing knowledge base
relevant to the science and practice of infectious
disease that supports the sustaining and devel-
opment of a distinct specialty, namely that of
infectious diseases. This specialty has evolved
from a traditional role of caring for infections
requiring isolation, such as diphtheria, polio and
formerly smallpox. However, the focus is now on
the ‘compromised host’, who is often subject to
endogenous and hospital-acquired infection.
Other populations include those with serious
community problems requiring hospitalisation,
as well as speciﬁc diseases such as HIV ⁄AIDS,
and increasingly hepatitis C, and those with
imported problems resulting from international
travel.
The number and distribution of infectious
disease specialists varies widely within Europe.
Some are largely linked to academic centres,
where research teaching and clinical practice are
closely interwoven. In other countries, district
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general hospitals have specialists in infectious
diseases, sometimes operating as part of the
general medical service, and sometimes inde-
pendently. The last few years have seen a dra-
matic increase in interest among medical
graduates to pursue careers in infectious diseases.
To meet this need, as well as the clinical service
requirements, additional posts have been created
within both academic and non-academic centres.
In some countries there has been enthusiasm for
hybrids who acquire joint training in microbio-
logy and infectious diseases (see workshop 3).
The role and function of the clinical infectious
disease specialists has at times been considered a
threat to clinical microbiologists, in terms of both
their laboratory expertise and their role in provi-
ding professional advice on clinical management
of infections. However, in many centres, it is
apparent that the training and expertise of the
disciplines, while sharing a common core know-
ledge base, provides the basis for acquiring skills
in laboratory and clinical practice that are com-
plementary and both strengthen the use of diag-
nostic services and improve the quality of patient
care. As a consequence, it was appropriate for the
workshop to discuss this ﬁnal question.
This topic clearly required consideration in
relation not only to the availability of expertise in
the various disciplines, but also to the size and
nature of the hospital facility in which the
disciplines might function. Smaller community-
based hospitals may not need the full repertoire of
expertise, although clinical microbiology and
infection control were viewed as core services.
Larger community hospitals and all teaching
centres require a full complement of expertise in
laboratory and clinical practice. What is important
is to ensure that there are adequate staff numbers
within the various disciplines to deliver on the
diagnostic and clinical services. Integration of
these disciplines within a department of infection
is an emerging concept that has been further
extended by proposals for infection centres,
which might be regionally based. The latter could
not only provide integration of infectious disease
and clinical microbiology services but also cap-
ture specialists in infection control ⁄ epidemiology,
sexually transmitted disease, travel medicine and
public health. Such departments and centres
could provide an ideal arrangement for better
meeting hospital, community and public health
needs, with the added advantages for staff train-
ing and development, education of undergradu-
ates and postgraduates, and research and
development.
The arguments against such arrangements
largely focused around the differences in educa-
tion and training of infection specialists in some
European countries and the way in which this
creates difﬁculties for closer integration. Likewise,
the fact that clinical microbiology is considered to
be a sub-specialty of laboratory medicine (biopa-
thology) in some countries (Belgium, Luxem-
bourg and Portugal) may make such integration
more difﬁcult. One major concern was the signi-
ﬁcant shortfall in trained expertise, which is either
currently critical in some countries or is likely to
become so because of the advancing age of the
current specialists. The importance of recruiting
talented new graduates was emphasised, together
with the need to better promote the career options
in the infection disciplines. The recent expansion
of the European Union may encourage movement
of well-trained specialists from eastern and cen-
tral European to western European countries,
which may in part address this professional
healthcare gap, but could create other problems.
The complexity and importance of this topic led
to a recommendation that a working party be
established under the aegis of the ESCMID to
investigate the current arrangements of infection
services in Europe and to make recommendations
for the future organisation of services relevant to
the diagnosis, management and prevention of
infection. This should take into consideration the
diverse historical, professional, cultural and
economic backgrounds of the many European
countries.
Finch et al. Organisation and management of infection 45
 2005 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 11 (Suppl. 1), 41–45
